Zenpep and Maxalt drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zenpep (pancrelipase (amylase;lipase;protease)) and Maxalt (rizatriptan benzoate). Common drug interactions include blood pressure increased among females and aspartate aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Zenpep and Maxalt. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Zenpep?

Zenpep has active ingredients of pancrelipase (amylase;lipase;protease). eHealthMe is studying from 5,529 Zenpep users. Check the latest studies of Zenpep.

What is Maxalt?

Maxalt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 12,754 Maxalt users. Check the latest studies of Maxalt.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

11 people who take Zenpep and Maxalt together, and have interactions are studied.

What are the common drug interactions of Zenpep and Maxalt, by gender? *:

female:

Blood pressure increased
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Drug hypersensitivity
Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
Food allergy
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Headache (pain in head)
Lung infection
Nausea (feeling of having an urge to vomit)
Nephrolithiasis (calculi in the kidneys)

male:

Aspartate aminotransferase increased
Chest discomfort
Weight increased
Diarrhoea
Distal intestinal obstruction syndrome (blockage of the intestines by thickened stool and occurs in individuals with cystic fibrosis)
Gamma-glutamyltransferase increased
Influenza like illness
Nausea (feeling of having an urge to vomit)
Nephrolithiasis (calculi in the kidneys)
Pain

What are the common drug interactions of Zenpep and Maxalt, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Gamma-glutamyltransferase increased
Influenza like illness
Nausea (feeling of having an urge to vomit)
Nephrolithiasis (calculi in the kidneys)
Pain
Secretion discharge
Tracheobronchitis (an inflammation or infection, which affects the trachea and bronchi of respiratory tract)
Weight increased
Aspartate aminotransferase increased
Chest discomfort

20-29:

Blood pressure increased
Headache (pain in head)
Vision blurred

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Drug hypersensitivity
Food allergy

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 6 people, 54.55%
Pain: 2 people, 18.18%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 18.18%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 9.09%
Fever: 1 person, 9.09%
Constipation: 1 person, 9.09%
Cough: 1 person, 9.09%
Drowsiness: 1 person, 9.09%
Dyspnea (difficult or laboured breathing): 1 person, 9.09%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Zenpep and Maxalt?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously